These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 15987224)

  • 1. Price differentiation and transparency in the global pharmaceutical marketplace.
    Ridley DB
    Pharmacoeconomics; 2005; 23(7):651-8. PubMed ID: 15987224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential pricing for pharmaceuticals: reconciling access, R&D and patents.
    Danzon PM; Towse A
    Int J Health Care Finance Econ; 2003 Sep; 3(3):183-205. PubMed ID: 14625999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Talkin' About a Resolution: Issues in the Push for Greater Transparency of Medicine Prices.
    Shaw B; Mestre-Ferrandiz J
    Pharmacoeconomics; 2020 Feb; 38(2):125-134. PubMed ID: 31956967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Risk sharing methods in middle income countries].
    Inotai A; Kaló Z
    Acta Pharm Hung; 2012; 82(1):43-52. PubMed ID: 22570986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmaceutical companies' variation of drug prices within and among countries can improve long-term social well-being.
    Lichtenberg FR
    Health Aff (Millwood); 2011 Aug; 30(8):1539-44. PubMed ID: 21821571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The economics of parallel trade.
    Danzon PM
    Pharmacoeconomics; 1998 Mar; 13(3):293-304. PubMed ID: 10178655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Price comparison of high-cost originator medicines in European countries.
    Vogler S; Zimmermann N; Babar ZU
    Expert Rev Pharmacoecon Outcomes Res; 2017 Apr; 17(2):221-230. PubMed ID: 27658050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. International differences in drug prices.
    Wagner JL; McCarthy E
    Annu Rev Public Health; 2004; 25():475-95. PubMed ID: 15015931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential pricing of new pharmaceuticals in lower income European countries.
    Kaló Z; Annemans L; Garrison LP
    Expert Rev Pharmacoecon Outcomes Res; 2013 Dec; 13(6):735-41. PubMed ID: 24219049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential Pricing of Pharmaceuticals: Theory, Evidence and Emerging Issues.
    Danzon PM
    Pharmacoeconomics; 2018 Dec; 36(12):1395-1405. PubMed ID: 30062518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do market components account for higher US prescription prices?
    Monaghan MJ; Monaghan MS
    Ann Pharmacother; 1996 Dec; 30(12):1489-94. PubMed ID: 8968463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. International trade and determinants of price differentials of insulin medicine.
    Helble M; Aizawa T
    Health Policy Plan; 2017 Feb; 32(1):1-10. PubMed ID: 27346189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Setting cost-effectiveness thresholds as a means to achieve appropriate drug prices in rich and poor countries.
    Danzon PM; Towse A; Mulcahy AW
    Health Aff (Millwood); 2011 Aug; 30(8):1529-38. PubMed ID: 21821570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value-based differential pricing: efficient prices for drugs in a global context.
    Danzon P; Towse A; Mestre-Ferrandiz J
    Health Econ; 2015 Mar; 24(3):294-301. PubMed ID: 24327269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The hidden cost of low prices: limited access to new drugs in India.
    Berndt ER; Cockburn IM
    Health Aff (Millwood); 2014 Sep; 33(9):1567-75. PubMed ID: 25201661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rx: higher prices.
    Kosterlitz J
    Natl J (Wash); 1993 Feb; 25(7):396-9. PubMed ID: 10125572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prices of pharmaceuticals in poor countries are much lower than in wealthy countries.
    Schweitzer SO; Comanor WS
    Health Aff (Millwood); 2011 Aug; 30(8):1553-61. PubMed ID: 21821573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmaceutical net price transparency across european markets: Insights from a multi-agent simulation model.
    Riccaboni M; Swoboda T; Van Dyck W
    Health Policy; 2022 Jun; 126(6):534-540. PubMed ID: 35459584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmaceutical research and development: a new system is needed.
    Prescrire Int; 2017 May; 26(182):130-135. PubMed ID: 30730675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. International drug price comparisons: quality assessment.
    Machado M; O'Brodovich R; Krahn M; Einarson TR
    Rev Panam Salud Publica; 2011 Jan; 29(1):46-51. PubMed ID: 21390419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.